Programming - BCVS Scientific Sessions 2022
Bridging Basic and Translational Science in Cardiovascular Disease
July 25–28, 2022
Chicago Hilton | Chicago, Illinois
July 25–28, 2022
Chicago Hilton | Chicago, Illinois
About this Meeting
The 16th annual BCVS 2022 Scientific Sessions has become the premier conference for molecular cardiovascular biology and disease. Sponsored by the American Heart Association Basic Cardiovascular Sciences Council, the world’s leading organization of cardiovascular scientists, the conference attracts leading researchers in fields such as microRNAs, cardiac gene and cell therapy, cardiac development and most recently tissue engineering and iPS cells.
BCVS 2022 Preliminary Program
| TIME (Central Time) | ACTIVITY |
|---|---|
| 9:00 a.m. – 9:15 a.m. | Early Career Opening Remarks |
| 9:15 a.m. – 10:15 a.m. | Early Career Session 1: Next Best Thing in Cardiovascular Research |
| 10:15 a.m. – 10:45 a.m. | Break/Exhibits |
| 10:45 a.m. – 11:45 a.m. | Early Career Session 2: Next Best Thing in Cardiovascular Research |
| 11:45 a.m. – 1:00 pm | Break/Exhibits/Lunch on Your Own |
| 1:00 p.m. – 1:30 p.m. | Opening Welcome |
| 1:30 p.m. – 2:45 p.m. | Genetic Basis of Cardiomyopathy |
| 2:45 p.m. – 3:15 p.m. | Break/Exhibits |
| 3:15 p.m. – 4:30 p.m. | Cardiac Repair, Cellular Reprogramming and Tissue Engineering |
| 4:30 p.m. – 7:00 p.m. | Poster Session 1 |
| TIME (Central Time) | ACTIVITY |
|---|---|
| 7:00 a.m. – 8:00 a.m. | Continental Breakfast |
| 7:00 a.m. – 8:00 a.m. | Women in Science Breakfast |
| 8:00 a.m. – 9:15 a.m. | Small RNAs, Exosomes and Extracellular Vesicles in Cardiovascular Disease |
| 9:15 a.m. – 9:45 a.m. | Refreshment Break/Exhibits |
| 9:45 a.m. – 11:00 a.m. | Advances in Cardiac Hypertrophy and Remodeling |
| 11:00 a.m. - Noon | Keynote Lecture |
| Noon – 1:30 p.m. | Lunch on Your Own/Poster Viewing/Exhibits Or Early Career Session |
| 1:30 p.m. – 2:45 p.m. | Hot Topics in Cardiac Fibrosis |
| 2:45 p.m. – 3:15 p.m. | Refreshment Break/Exhibits |
| 3:15 p.m. – 4:30 p.m. | Bench to Bedside: Cardiovascular Therapeutics not Lost in Translation |
| 4:30 p.m. – 7:00 p.m. | Poster Session 2 |
| TIME (Central Time) | ACTIVITY |
|---|---|
| 7:00 a.m. – 8:00 a.m. | Continental Breakfast/Registration/Exhibits |
| 8:00 a.m. – 9:15 a.m. | Novel Mechanisms of HFpEF and HFrEF |
| 9:15 a.m. – 9:45 a.m. | Refreshment Break/Exhibits |
| 9:45 a.m. – 11:00 a.m. | Cardio-oncology and Reverse Cardio-oncology |
| 11:00 a.m. – 11:45 a.m. | Outstanding Early Career Investigator Award Competition |
| 11:45 a.m. – 1:30 p.m. | Lunch on Your Own Or Lunch and Learn |
| 1:30 p.m. – 2:45 p.m. | Metabolic Cues in Heart Disease |
| 2:45 p.m. – 3:15 p.m. | Refreshment Break/Exhibits |
| 3:15 p.m. – 4:30 p.m. | Epigenetics and Transcriptional Control of Heart Disease |
| 4:30 p.m. – 7:00 p.m. | Poster Session 3 |
| 7:00 – 9:00 pm | Council Dinner |
| TIME (Central Time) | ACTIVITY |
|---|---|
| 7:00 a.m. – 8:00 a.m. | Continental Breakfast/Registration/Exhibits |
| 8:00 a.m. – 9:15 a.m. | Cardio-immunology, Inflammation and Cardiac Pathophysiology |
| 9:15 a.m. – 9:45 a.m. | Refreshment Break/Exhibits |
| 9:45 a.m. – 11:00 a.m. | Interorgan Communications in Heart Disease |
| 11:00 a.m. | Closing Remarks |
Target Audience
- Basic cardiovascular scientists
- Molecular/cellular biologists
- Physiologists
- Translational investigators
- Clinical trialists
- Practicing cardiologists
- Cardiovascular nurses and pharmacists
Learning Objectives
At the conclusion of the conference, participants will be able to:
- Understand new developments in cardiovascular pathophysiology and implications for future therapeutics.
- Discuss the lasted research on cardiovascular inflammation and how this links to heart failure.
- Describe current knowledge gaps in research and understanding of cardiovascular disease.
- Recognize the basis of cardio-immunology and the link to cardio-oncology.
- Explain the potential role of and challenges involved in the use of big data analytics in precision medicine to guide treatment in cardiovascular disease including COVID-19 related injury.